keyword
MENU ▼
Read by QxMD icon Read
search

Febrile neutropenia in inflammatory disease

keyword
https://www.readbyqxmd.com/read/27695085/gm-csf-down-regulates-tlr-expression-via-the-transcription-factor-pu-1-in-human-monocytes
#1
Kambis Sadeghi, Lukas Wisgrill, Isabelle Wessely, Susanne C Diesner, Simone Schüller, Celia Dürr, Armando Heinle, Monika Sachet, Arnold Pollak, Elisabeth Förster-Waldl, Andreas Spittler
Toll-like receptors (TLR) are crucial sensors of microbial agents such as bacterial or viral compounds. These receptors constitute key players in the induction of inflammation, e.g. in septic or chronic inflammatory diseases. Colony-stimulating factors (CSFs) such as granulocyte-macrophage-CSF (GM-CSF) or granulocyte-CSF (G-CSF) have been extensively investigated in their capacity to promote myelopoiesis in febrile neutropenia or to overcome immunosuppression in patients suffering from sepsis-associated neutropenia or from monocytic immunoincompetence...
2016: PloS One
https://www.readbyqxmd.com/read/27400951/adrenomedullin-predicts-high-risk-and-culture-positivity-in-children-with-solid-tumors-suffering-from-neutropenic-fever
#2
Vural Kesik, Erman Ataş, Yasemin Gülcan Kurt, Fevzi Nuri Aydın, Oğuzhan Babacan, Mustafa Gülgün, Nadir Korkmazer
AIM OF STUDY: Neutropenic fever is a source of morbidity and mortality in children with cancer. It is not possible to detect the causative agent in cultures in most cases; the research for a marker that can show the severity of the disease is ongoing. We evaluated the role of adrenomedullin (ADM) at predicting prognosis on patients with febrile neutropenia, which has been proven to be a good prognostic marker for diseases with high morbidity and mortality, such as heart failure, ischemic ventricular dysfunction, sepsis, and systemic inflammatory response syndrome...
September 2016: Journal of Infection and Chemotherapy: Official Journal of the Japan Society of Chemotherapy
https://www.readbyqxmd.com/read/27179402/5-year-analysis-of-neoadjuvant-pertuzumab-and-trastuzumab-in-patients-with-locally-advanced-inflammatory-or-early-stage-her2-positive-breast-cancer-neosphere-a-multicentre-open-label-phase-2-randomised-trial
#3
Luca Gianni, Tadeusz Pienkowski, Young-Hyuck Im, Ling-Ming Tseng, Mei-Ching Liu, Ana Lluch, Elżbieta Starosławska, Juan de la Haba-Rodriguez, Seock-Ah Im, Jose Luiz Pedrini, Brigitte Poirier, Paolo Morandi, Vladimir Semiglazov, Vichien Srimuninnimit, Giulia Valeria Bianchi, Domenico Magazzù, Virginia McNally, Hannah Douthwaite, Graham Ross, Pinuccia Valagussa
BACKGROUND: In the primary analysis of the NeoSphere trial, patients given neoadjuvant pertuzumab, trastuzumab, and docetaxel showed a significantly improved pathological complete response compared with those given trastuzumab and docetaxel after surgery. Here, we report 5-year progression-free survival, disease-free survival, and safety. METHODS: In this multicentre, open-label, phase 2 randomised trial in hospitals and medical clinics, treatment-naive adults with locally advanced, inflammatory, or early-stage HER2-positive breast cancer were randomly assigned (1:1:1:1) to receive four neoadjuvant cycles of trastuzumab (8 mg/kg loading dose, followed by 6 mg/kg every 3 weeks) plus docetaxel (75 mg/m(2) every 3 weeks, increasing to 100 mg/m(2) from cycle 2 if tolerated; group A), pertuzumab (840 mg loading dose, followed by 420 mg every 3 weeks) and trastuzumab plus docetaxel (group B), pertuzumab and trastuzumab (group C), or pertuzumab and docetaxel (group D)...
June 2016: Lancet Oncology
https://www.readbyqxmd.com/read/27149134/adverse-reaction-to-cetuximab-an-epidermal-growth-factor-receptor-inhibitor
#4
Daška Štulhofer Buzina, Ivana Martinac, Daniela Ledić Drvar, Romana Čeović, Ivan Bilić, Branka Marinović
Dear Editor, Inhibition of the epidermal growth factor receptor (EGFR) is a new strategy in treatment of a variety of solid tumors, such as colorectal carcinoma, non-small cell lung cancer, squamous cell carcinoma of the head and neck, and pancreatic cancer (1). Cetuximab is a chimeric human-murine monoclonal antibody against EGFR. Cutaneous side effects are the most common adverse reactions occurring during epidermal growth factor receptor inhibitors (EGFRI) therapy. Papulopustular rash (acne like rash) develop with 80-86% patients receiving cetuximab, while xerosis, eczema, fissures, teleangiectasiae, hyperpigmentations, and nail and hair changes occur less frequently (2)...
April 2016: Acta Dermatovenerologica Croatica: ADC
https://www.readbyqxmd.com/read/26434104/pentraxin-3-as-a-biomarker-for-febrile-neutropenia-in-patients-with-lung-cancer
#5
Noriko Takeda, Kazuhisa Asai, Naoki Ijiri, Norio Yamamoto, Tetsuya Watanabe, Hiroshi Kamoi, Hiroshi Kanazawa, Kazuto Hirata
BACKGROUND: Pentraxin-3 (PTX3) is a newly discovered biomarker for various inflammatory conditions. We measured plasma PTX3 levels in patients with febrile neutropenic lung cancer and examined the utility of PTX3 levels as a biomarker for febrile neutropenia. METHODS: Fourteen patients with febrile neutropenic lung cancer were enrolled in the study. In addition, 10 untreated lung cancer patients and 12 healthy adults were enrolled as a disease control group and a healthy control group, respectively...
June 2015: Osaka City Medical Journal
https://www.readbyqxmd.com/read/26270467/bacterial-landscape-of-bloodstream-infections-in-neutropenic-patients-via-high-throughput-sequencing
#6
Peter Gyarmati, Christian Kjellander, Carl Aust, Mats Kalin, Lars Öhrmalm, Christian G Giske
BACKGROUND: Bloodstream infection (BSI) is a common and potentially life-threatening complication in patients with hematological malignancies and therapy-induced neutropenia. Administration of broad spectrum antibiotics has substantially decreased the mortality rate in febrile neutropenia, but bacterial infection is documented in only one-third or fewer of the cases. BSI is typically diagnosed by blood culture; however, this method can detect only culturable pathogens. METHODS: In the present study, a total of 130 blood samples from hematological patients receiving dose-intensive antitumoural treatment were subjected to 16S rRNA PCR and 62 of them were cultured...
2015: PloS One
https://www.readbyqxmd.com/read/25793039/periodic-fever-a-review-on-clinical-management-and-guideline-for-iranian-patients-part-i
#7
Zahra Ahmadinejad, Sedigeh Mansori, Vahid Ziaee, Neda Alijani, Yahya Aghighi, Nima Parvaneh, Mohammad-Hassan Mordinejad
Periodic fever syndromes are a group of diseases characterized by episodes of fever with healthy intervals between febrile episodes. The first manifestation of these disorders are present in childhood and adolescence, but infrequently it may be presented in young and middle ages. Genetic base has been known for all types of periodic fever syndromes except periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA). Common periodic fever disorders are Familial Mediterranean fever (FMF) and PFAPA...
February 2014: Iranian Journal of Pediatrics
https://www.readbyqxmd.com/read/25284133/hemophagocytic-lymphohistiocytosis-in-a-patient-with-goodpasture-s-syndrome-a-rare-clinical-association
#8
Alina Basnet, Michelle R Cholankeril
BACKGROUND: Hemophagocytic lymphohistiocytosis (HLH) is a life-threatening clinical syndrome. HLH can occur in the setting of an autoimmune disease, chronic immunosuppression, malignancy, and infection. We discuss a rare case of a young woman who was diagnosed with Goodpasture's syndrome that was most likely complicated by HLH. To the best of our knowledge, this is the first report of HLH in the setting of this rare autoimmune disease. CASE REPORT: A 31-year-old woman who was diagnosed with Goodpasture's syndrome 7 years prior presented with febrile neutropenia...
2014: American Journal of Case Reports
https://www.readbyqxmd.com/read/25161154/fluoroquinolones-in-pediatrics-review-of-hospital-prescription-use-over-2-years
#9
Mathieu Genuini, Sonia Prot-Labarthe, Olivier Bourdon, Catherine Doit, Yannick Aujard, Jérôme Naudin, Mathie Lorrot
OBJECTIVE: Numerous studies have shown that the tolerance of children to fluoroquinolones (FQs) is satisfactory, and some indications have been recently agreed upon. However, vigilance is required when prescribing FQ to children. The aim of our study was to describe the prescription of FQs to children hospitalized in our hospital. MATERIALS AND METHODS: This is a chart retrospective observational study at the Robert-Debré teaching Hospital between January 2009 and December 2010...
November 2014: International Journal of Clinical Pharmacology and Therapeutics
https://www.readbyqxmd.com/read/24755510/malakoplakia-of-liver-report-of-two-cases
#10
Noha Botros, Sen R Yan, Ian R Wanless
Malakoplakia is an unusual chronic inflammatory condition characterized by the presence of Michaelis-Gutmann bodies. Patients with malakoplakia often have an immunodeficiency state. It is believed that malakoplakia results from a defective macrophage response to phagocytosed bacteria. Malakoplakia most commonly affects the genitourinary tract. Cases confined to the liver are rare, with only five cases described in the literature. We report two cases of malakoplakia of liver; both were incidental autopsy findings...
July 2014: Pathology, Research and Practice
https://www.readbyqxmd.com/read/24642872/distinct-inflammatory-mediator-patterns-characterize-infectious-and-sterile-systemic-inflammation-in-febrile-neutropenic-hematology-patients
#11
Christine Wennerås, Lars Hagberg, Rune Andersson, Lars Hynsjö, Anders Lindahl, Marcin Okroj, Anna M Blom, Peter Johansson, Björn Andreasson, Johan Gottfries, Agnes E Wold
BACKGROUND: Invasive infections and sterile tissue damage can both give rise to systemic inflammation with fever and production of inflammatory mediators. This makes it difficult to diagnose infections in patients who are already inflamed, e.g. due to cell and tissue damage. For example, fever in patients with hematological malignancies may depend on infection, lysis of malignant cells, and/or chemotherapy-induced mucosal damage. We hypothesized that it would be possible to distinguish patterns of inflammatory mediators characterizing infectious and non-infectious causes of inflammation, respectively...
2014: PloS One
https://www.readbyqxmd.com/read/24216440/update-on-new-medicinal-applications-of-gentamicin-evidence-based-review
#12
REVIEW
Changhua Chen, Yumin Chen, Pinpin Wu, Baoyuan Chen
Gentamicin (GM) was discovered in 1963 and was introduced into parenteral usage in 1971. Since then, GM has been widely used in medicinal applications. The Food and Drug Administration of the United States approved the routine prescription of GM to treat the following infectious disorders: infection due to Klebsiella pneumoniae, Escherichia coli, Serratia marcescens, Citrobacter spp., Enterobacteriaceae spp., Pseudomonas spp.; Staphylococcus infectious disease; bacterial meningitis; bacterial sepsis of newborns; bacterial septicemia; infection of the eye, bone, skin and/or subcutaneous tissue; infective endocarditis; peritoneal dialysis-associated peritonitis due to Pseudomonas and other gram-negative organisms; peritonitis due to gastrointestinal tract infections; respiratory tract infections; and urinary tract infectious disease...
February 2014: Journal of the Formosan Medical Association, Taiwan Yi Zhi
https://www.readbyqxmd.com/read/24168151/hematopoietic-growth-factors-support-in-the-elderly-cancer-patients-treated-with-antiblastic-chemotherapy
#13
REVIEW
Maurizio Rupolo, Arben Lleshi, Bruno Cacopardo, Mariagrazia Michieli, Massimiliano Berretta
The 60% of tumors affected patients >65years of age and the future previsions are considering an amount of 70% after 2030. Elderly Patients presents multiple comorbidity, polipharmacy, and disability. Geriatric assessment helps physicians to take the best therapeutic decisions. Clinical conditions influence efficacy and tolerability of chemotherapy. Prophylactic use of G-CSF after chemotherapy lowers the rate and length of severe neutropenia , and decreases the episodes of febrile neutropenia. Anemia is a hematologic condition associated with ageing , but is frequently associated to concomitant chronic disease...
November 2013: Anti-cancer Agents in Medicinal Chemistry
https://www.readbyqxmd.com/read/24120354/prolonged-and-recurrent-fevers-in-children
#14
REVIEW
Gary S Marshall
Some children referred for prolonged fever are actually not having elevated temperatures; the approach here requires dissection of the history and correction of health misperceptions. Others have well-documented fevers associated with clinical, laboratory, or epidemiologic findings that should point to a specific diagnosis. "Fever-of-Unknown-Origin" (FUO) is the clinical scenario of daily fever for ≥ 14 days that defies explanation after a careful history, physical examination, and basic laboratory tests...
January 2014: Journal of Infection
https://www.readbyqxmd.com/read/24102275/hematopoietic-growth-factor-support-in-the-elderly-treated-with-chemotherapy
#15
M Rupolo, M Berretta
The 60% of tumors affected patients >65years of age and the future previsions are considering an amount of 70% after 2030. Elderly Patients presents multiple comorbidity, polipharmacy, and disability. Geriatric assessment helps physicians to take the best therapeutic decisions. Clinical conditions influence efficacy and tolerability of chemotherapy. Prophylactic use of G-CSF after chemotherapy lowers the rate and length of severe neutropenia , and decreases the episodes of febrile neutropenia. Anemia is a hematologic condition associated with ageing , but is frequently associated to concomitant chronic disease...
October 9, 2013: Anti-cancer Agents in Medicinal Chemistry
https://www.readbyqxmd.com/read/23990311/febrile-neutropenia-in-hematologic-malignancies
#16
REVIEW
Michael K Keng, Mikkael A Sekeres
Febrile neutropenia (FN) can occur at any time during the course of a malignancy, especially hematologic malignancies, from diagnosis to end-stage disease. The majority of FN episodes are typically confined to the period of initial diagnosis and active treatment. Because of suppressed inflammatory responses, fever is often the sole sign of infection. As FN is a true medical emergency, prompt identification of and intervention in FN can prolong survival and improve quality of life. This article reviews FN in the setting of hematologic malignancies, specifically myelodysplastic syndromes and acute leukemias, providing an overview of the definition of fever and neutropenia, diagnostic approach, categories of risk/risk assessment, management in patients at low and high risk, and prophylaxis of infections...
December 2013: Current Hematologic Malignancy Reports
https://www.readbyqxmd.com/read/23905616/the-use-of-fdg-pet-ct-in-patients-with-febrile-neutropenia
#17
REVIEW
Fidel J Vos, Chantal P Bleeker-Rovers, Wim J G Oyen
Fever is a frequent complication of neutropenia induced by the treatment of various neoplasms. This is referred to as febrile neutropenia, which is considered to be a sign of a potentially life-threatening infectious complication until proven otherwise. However, most infectious foci do not have localizing signs and symptoms owing to the lack of inflammatory infiltrates during neutropenia. At the same time, recent studies also showed that febrile neutropenia is not a specific indicator for infection. An increase in C-reactive protein and fever may initially be caused by inflammation of the digestive tract mucosa due to cytotoxic treatment of hematologic malignancies...
September 2013: Seminars in Nuclear Medicine
https://www.readbyqxmd.com/read/23569311/averel-a-randomized-phase-iii-trial-evaluating-bevacizumab-in-combination-with-docetaxel-and-trastuzumab-as-first-line-therapy-for-her2-positive-locally-recurrent-metastatic-breast-cancer
#18
RANDOMIZED CONTROLLED TRIAL
Luca Gianni, Gilles H Romieu, Michail Lichinitser, Sergio V Serrano, Mauro Mansutti, Xavier Pivot, Paola Mariani, Fabrice Andre, Arlene Chan, Oleg Lipatov, Stephen Chan, Andrew Wardley, Richard Greil, Nicola Moore, Sylvie Prot, Celine Pallaud, Vladimir Semiglazov
PURPOSE The AVEREL trial [A Study of Avastin (Bevacizumab) in Combination With Herceptin (Trastuzumab)/Docetaxel in Patients With HER2-Positive Metastatic Breast Cancer] evaluated first-line bevacizumab-containing therapy for human epidermal growth factor receptor 2 (HER2) -positive locally recurrent/metastatic breast cancer (LR/MBC). PATIENTS AND METHODS Patients with measurable/evaluable HER2-positive LR/MBC who had not received trastuzumab or chemotherapy for LR/MBC were stratified by prior adjuvant trastuzumab, prior (neo)adjuvant taxane, hormone receptor status, and measurable disease and were randomly assigned to receive docetaxel 100 mg/m(2) plus trastuzumab 8 mg/kg loading dose followed by 6 mg/kg either with bevacizumab 15 mg/kg or without bevacizumab, all administered every 3 weeks...
May 10, 2013: Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology
https://www.readbyqxmd.com/read/23492305/mein-kind-ist-immer-krank-wann-ist-es-wirklich-krank-vom-periodischen-fiebersyndrom-bis-zum-immundefekt
#19
Duppenthaler
Fever is one of the main symptoms leading to medical evaluation. Not only infections cause fever but also inflammatory disorders. To distinguish one from another, a thorough medical history and clinical evaluation are needed. Sometimes, only the clinical course will reveal the diagnosis. PFAPA-Syndrome (periodic fever, aphthous stomatitis, pharyngitis, adenitis) is the most frequent periodic fever syndrome in Switzerland. No diagnostic test is available to support the diagnosis. Some important diseases have to be ruled out, such as Immunodeficiency, cyclic neutropenia, chronic viral infections and rheumatologic disorders...
October 1, 2006: Therapeutische Umschau. Revue Thérapeutique
https://www.readbyqxmd.com/read/23408310/transient-neutropenia-in-children-with-febrile-illness-and-associated-infectious-agents-2-years-follow-up
#20
Ourania Alexandropoulou, Lydia Kossiva, Fotis Haliotis, Maria Giannaki, Maria Tsolia, I P Panagiotou, Kyriaki Karavanaki
The aim of the study was to identify the relationship of acquired neutropenia with childhood infections and to assess its clinical course, complications, and outcome. Children admitted to two pediatric wards over a 4-year period with febrile neutropenia were prospectively investigated for underlying infections with inflammatory markers, cultures of body fluids, and serological tests. The study included 161 previously healthy children with febrile neutropenia/leukopenia aged (mean ± SD) 3.02 ± 3.86 years (range, 0...
June 2013: European Journal of Pediatrics
keyword
keyword
58361
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"